Tag: covid-19 saliva screening test potential market trends

  • Unlocking the Future of the COVID-19 Saliva Screening Test Potential Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

    Unlocking the Future of the COVID-19 Saliva Screening Test Potential Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What key factors are powering the surge in the covid-19 saliva screening test potential market right now?

    The COVID-19 saliva screening test potential market has expanded strongly in recent years. It will grow from $3.9 billion in 2024 to $4.29 billion in 2025, at a compound annual growth rate (CAGR) of 9.9%. This growth is due to the potential for home testing, the unprecedented need for diagnostic testing, rising public awareness, and increased investment in research and development.

    How fast Is the covid-19 saliva screening test potential market expected to grow, and what’s its future value?

    The COVID-19 saliva screening test market is expected to grow to $6.17 billion by 2029, at a CAGR of 9.5%. Growth is attributed to the integration of screening programs, regulatory support, demand for rapid point-of-care tests, population growth, and e-commerce. Trends include increased adoption in non-healthcare settings, digital health platform integration, next-gen technologies, technological advancements, and strategic partnerships.

    Get your covid-19 saliva screening test potential market report here!

    https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

    What are the leading drivers of growth in the covid-19 saliva screening test potential market?

    The growing healthcare expenditure is expected to spur the growth of the COVID-19 saliva screening test market. Healthcare expenditure refers to the total spending on healthcare services and products, including prescription medications, hospital stays, doctor visits, medical devices, and public health campaigns. Factors like minimally invasive surgeries, advanced diagnostic technologies, and increased investment in R&D for new drugs contribute to the rise in healthcare spending. This financial growth supports the broader use of COVID-19 saliva screening tests, enhancing pandemic control efforts and improving health outcomes. For instance, in 2022, the UK’s healthcare expenditure reached $354.88 billion (£283 billion), marking a 0.7% increase from 2021, according to the Office for National Statistics. This surge in healthcare spending supports the growth of the COVID-19 saliva screening test market.

    What are the key segments defining the covid-19 saliva screening test potential market?

    The COVID-19 saliva screening test potential market covered in this report is segmented –

    1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations

    2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9

    3) By Mode Of Testing: Centralized Testing, Decentralized Testing

    Subsegments:

    1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports

    2) By Sports Arenas: Stadiums, Arenas, Event Halls

    3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs

    4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks

    5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas

    6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites

    7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers, Other Public Or Private Venues

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp

    Who are the key players steering the development of the covid-19 saliva screening test potential market?

    Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.

    What emerging trends are influencing the growth of the covid-19 saliva screening test potential market?

    Companies in the COVID-19 saliva screening test market are developing data-sharing platforms to enhance communication and collaboration in testing and tracking. In May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. This initiative focuses on improving public health emergency responses, ensuring efficient strategies during pandemics and other crises.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16026

    Which regions are most influential in expanding the covid-19 saliva screening test potential market?

    North America was the largest region in the COVID-19 saliva screening test potential market in 2023. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Blood Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

    Carrier Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

    Cellular Health Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Trends and Insights into the COVID-19 Saliva Screening Test Potential Market: Growth Rate and Opportunities to 2034

    Key Trends and Insights into the COVID-19 Saliva Screening Test Potential Market: Growth Rate and Opportunities to 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Future CAGR is Anticipated for the COVID-19 Saliva Screening Test Potential Market Over the 2025–2034 Period?

    The potential market for the COVID-19 saliva screening test has seen robust expansion in the past few years. It is anticipated to swell from $3.9 billion in 2024 to $4.29 billion in 2025, marking a compound annual growth rate (CAGR) of 9.9%. Factors contributing to the growth during the historic period include the potential for at-home testing, an unparalleled demand for diagnostic testing, heightened public awareness, and investment into research and development.

    There is a prediction for significant expansion of the COVID-19 saliva screening test potential market, expecting to reach $6.17 billion by 2029, marking a compound annual growth rate (CAGR) of 9.5%. This predicted growth during the forecast period can be credited to factors such as its incorporation into screening programs, increased demand for quick, on-the-spot COVID-19 tests, regulatory backing, demographic growth, and the emergence of e-commerce. Upcoming trends for this period encompass their growing use in non-medical settings, connection with digital health infrastructures, launch of pioneering technologies, advancements in technology, and strategic collaborations.

    What Key Drivers Are Accelerating the Growth of the COVID-19 Saliva Screening Test Potential Market During the Forecast Period?

    The upward trend in healthcare spending is predicted to fuel the expansion of the COVID-19 saliva screening test potential market. Healthcare spending embodies the total costs incurred on health-related products and services, such as prescription medication, hospitalizations, doctor consultations, medical devices, and public health initiatives. Driving the rise in this expenditure are several variables, including the adoption of minimally invasive procedures, advanced diagnostic technology, the discovery and development of new drugs, the use of health services, and specialized drugs. The increased investment in healthcare could provide the necessary resources and aid to maximize the potential of COVID-19 saliva screening tests, making pandemic control more effective and improving overall public health. For example, the Office for National Statistics, a UK-based statistical entity on epilepsy, stated that healthcare spending in the UK rose to around $354.88 billion (£283 billion) in 2022, a nominal rise of 0.7% compared to the previous year’s spending. Thus, the escalating healthcare spending is steering the growth of the COVID-19 saliva screening test potential market.

    Get Your Free Sample of the Global COVID-19 Saliva Screening Test Potential Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp

    Who Are the Influential Players Fueling Innovation and Growth in the COVID-19 Saliva Screening Test Potential Market?

    Major companies operating in the COVID-19 saliva screening test potential market are:

    • Roche Diagnostics Corporation

    • Thermo Fisher Scientific Inc.

    • Abbott Laboratories

    • Becton Dickinson and Company

    • Danaher Corporation

    What Impact Are Industry Trends Having on the COVID-19 Saliva Screening Test Potential Market’s Future Prospects?

    Leading businesses involved in the market for COVID-19 saliva screening tests are concentrating on creating state-of-the-art technologies like data-sharing platforms. These platforms augment real-time communication and cooperation between healthcare providers, laboratories, and public health authorities. The goal is to improve the speed and accuracy of testing, monitoring, and responding during the outbreak. Data-sharing platforms are electronic systems that allow the safe transfer of data between stakeholders such as healthcare providers, researchers, and organizations. They enable collaboration and accessibility of information, enhancing decision-making, productivity, and results across diverse sectors. For example, the Center for Healthcare Readiness was launched by Mount Sinai Health System, a healthcare network in the US, in May 2024. The Center aims to improve public health emergency response strategies to ensure healthcare systems are prepared for large-scale crises like pandemics or natural catastrophes. It strives to beef up the capabilities of the Mount Sinai Health System and work in close cooperation with local, regional, and federal partners to develop thorough readiness plans.

    Get Instant Access to the Global COVID-19 Saliva Screening Test Potential Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

    How Are the Key Segments of the COVID-19 Saliva Screening Test Potential Market Impacting Its Expansion and Revenue Streams?

    The COVID-19 saliva screening test potential market covered in this report is segmented –

    1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations

    2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9

    3) By Mode Of Testing: Centralized Testing, Decentralized Testing

    Subsegments:

    1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports

    2) By Sports Arenas: Stadiums, Arenas, Event Halls

    3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs

    4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks

    5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas

    6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites

    7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers, Other Public Or Private Venues

    What Regions Are Leading the Growth Trajectory of the COVID-19 Saliva Screening Test Potential Market?

    North America was the largest region in the COVID-19 saliva screening test potential market in 2023. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Key Characteristics That Define the COVID-19 Saliva Screening Test Potential Market?

    The COVID-19 saliva screening test potential refers to the potential advantages and capabilities that saliva-based tests for detecting SARS-CoV-2, the virus that causes COVID-19, could offer compared to traditional methods such as nasopharyngeal or oropharyngeal swab tests. Their potential lies in improving testing accessibility, patient acceptance, cost-effectiveness, and safety while enabling new testing strategies and approaches to manage the COVID-19 pandemic better.

    Browse Through More Similar Reports By The Business Research Company:

    Blood Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

    Carrier Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

    Cellular Health Screening Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive COVID-19 Saliva Screening Test Potential Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive COVID-19 Saliva Screening Test Potential Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the COVID-19 Saliva Screening Test Potential Market from 2024 to 2033?
    The COVID-19 saliva screening test market has seen significant growth recently, projected to rise from $3.57 billion in 2023 to $3.90 billion in 2024, with a compound annual growth rate (CAGR) of 9.3%. This growth is driven by the potential for home testing, heightened demand for diagnostic tests, increased public awareness, and investments in research and development.

    The COVID-19 saliva screening test market is projected to grow significantly, reaching $5.64 billion by 2028, with a CAGR of 9.6%. This growth is driven by the integration of screening programs, regulatory support, the demand for rapid point-of-care tests, population growth, and the expansion of e-commerce. Key trends include increased use in non-healthcare environments, integration with digital health platforms, new technologies, technological advancements, and strategic partnerships.

    Claim Your Free Sample of the Global COVID-19 Saliva Screening Test Potential Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=16026&type=smp

    What Key Factors Are Fueling the Growth of the COVID-19 Saliva Screening Test Potential Market?
    The increase in healthcare spending is expected to drive the growth of the COVID-19 saliva screening test potential market in the coming years. Healthcare expenditure includes all spending related to healthcare goods and services, such as medications, hospital stays, and public health initiatives. This spending is rising due to factors like minimally invasive surgeries, advanced diagnostic tools, and increased R&D for new drugs. Higher healthcare spending provides resources to enhance the effectiveness of COVID-19 saliva screening tests, contributing to better pandemic management and public health outcomes. For example, the Office for National Statistics reported a 9.7% growth in the UK’s healthcare spending in real terms in May 2023, with total spending reaching $367.25 billion in 2021. Thus, the rising healthcare expenditure is driving the growth of the COVID-19 saliva screening test potential market.

    What Are the Major Segments of the COVID-19 Saliva Screening Test Potential Market?
    1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
    2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
    3) By Mode of Testing: Centralized Testing, Decentralized Testing

    What New Trends Are Transforming the COVID-19 Saliva Screening Test Potential Market?
    Firms in the COVID-19 saliva screening test potential market are focused on developing saliva testing programs to expand their offerings. In April 2021, Mount Sinai Health System, a US healthcare network, launched a PCR saliva testing program for quick and noninvasive COVID-19 testing, with plans to process up to 100,000 tests daily, emphasizing the importance of testing in controlling the virus spread.

    Order Now for Fast Delivery of Your COVID-19 Saliva Screening Test Potential Market Report!
    https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

    Which Regions Are Driving Growth in the COVID-19 Saliva Screening Test Potential Market?
    North America was the largest region in the COVID-19 saliva screening test potential market in 2023. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The COVID-19 Saliva Screening Test Potential Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the covid-19 saliva screening test potential market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The COVID-19 Saliva Screening Test Potential Market Include

    1. COVID-19 Saliva Screening Test Potential Market Executive Summary
    2. COVID-19 Saliva Screening Test Potential Market Segments
    3. COVID-19 Saliva Screening Test Potential Market Size And Template Market Growth Rate
    4.  Key COVID-19 Saliva Screening Test Potential Market Trends
    5. Major COVID-19 Saliva Screening Test Potential Market Drivers
    ……
    25. Key Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential Market
    26. Top COVID-19 Saliva Screening Test Potential Companies
    27. COVID-19 Saliva Screening Test Potential Market Opportunities And Strategies
    28. COVID-19 Saliva Screening Test Potential Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Drug Screening Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

    Security Screening Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

    Employment Screening Services Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/employment-screening-services-global-market-report

    Learn More About The Business Research Company
    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/
    Americas +1 3156230293
    Asia +44 2071930708
    Europe +44 2071930708
    Email us at info@tbrc.info

    Follow us on:
    LinkedIn: https://in.linkedin.com/company/the-business-research-company
    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • COVID-19 Saliva Screening Test Potential Market Report 2024: Market Size, Drivers, And Trends

    COVID-19 Saliva Screening Test Potential Market Report 2024: Market Size, Drivers, And Trends

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Market Overview

    The COVID-19 saliva screening test market has shown significant growth, expanding from $3.57 billion in 2023 to an expected $3.90 billion in 2024, reflecting a compound annual growth rate (CAGR) of 9.3%. This robust growth is driven by:

    • Potential for home testing
    • Unprecedented need for diagnostic testing
    • Increased public awareness
    • Investment in research and development

    Future Market Projections

    The market is anticipated to continue its upward trajectory, reaching $5.64 billion by 2028 with a CAGR of 9.6%. Key factors contributing to this growth include:

    • Integration with screening programs
    • Regulatory support
    • Growing demand for speedy, point-of-care tests
    • Increasing population
    • Rise of e-commerce

    Major Trends

    • Increased adoption in non-healthcare settings
    • Integration with digital health platforms
    • Emergence of next-generation technologies
    • Technological advancements
    • Strategic partnerships

    View More On The COVID-19 Saliva Screening Test Potential Market Report 2024 – https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

    Impact of Healthcare Expenditure

    Increasing healthcare expenditure is a significant driver of market growth. Factors contributing to higher healthcare spending include:

    • Minimally invasive surgeries
    • Cutting-edge diagnostic tools
    • Increased R&D for new drugs
    • Greater utilization of healthcare services
    • Specialty medications

    Example

    In the UK, healthcare expenditure grew by 9.7% in real terms and 9.4% in nominal terms in 2021. This included a substantial increase in spending on pharmaceuticals and preventative care, highlighting the importance of resource allocation in pandemic management and public health outcomes.

    Key Players in the Market

    Several major companies dominate the COVID-19 saliva screening test market:

    • Roche Diagnostics Corporation
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Danaher Corporation
    • Hologic Inc.
    • PerkinElmer Inc.
    • Quidel Corporation
    • Cepheid
    • Seegene Inc.

    Innovative Technologies and Programs

    Innovation is a cornerstone of market growth, with companies developing advanced testing programs to meet rising demand. For instance:

    Mount Sinai Health System

    In April 2021, Mount Sinai Health System launched a COVID-19 PCR Saliva Testing program. Key features of this program include:

    • Quick, noninvasive, and precise testing
    • Scalability to process up to 100,000 daily tests
    • Results within 24 hours for most tests
    • Child-friendly and comfortable testing options

    Strategic Acquisitions

    Strategic acquisitions are bolstering market presence and expanding capabilities:

    Hologic Inc. and Mobidiag Oy

    In June 2021, Hologic Inc. acquired Mobidiag Oy, enhancing its diagnostics market presence with innovative near-patient molecular diagnostic instruments and tests. This acquisition highlights the strategic moves companies are making to stay competitive and expand their product offerings.

    Market Segmentation

    The COVID-19 saliva screening test market is segmented by:

    Location

    • Travel Stations
    • Sports Arenas
    • Entertainment Venues
    • Corporate Campus Environments
    • Universities and Colleges
    • Factories
    • Other Locations

    Technology

    • Fluorescence-Labelled Antigen
    • RT-PCR
    • CRISPR-Cas9

    Mode of Testing

    • Centralized Testing
    • Decentralized Testing

    Regional Insights

    North America was the largest region in the COVID-19 saliva screening test market in 2023, driven by strong healthcare infrastructure, regulatory support, and high public awareness.

    The continuous advancements and strategic initiatives in the COVID-19 saliva screening test market underscore its critical role in pandemic management and public health. As the market evolves, it will play a pivotal role in shaping the future of diagnostic testing and healthcare delivery.

    Request A Sample Of The Global COVID-19 Saliva Screening Test Potential Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=16026&type=smp